Colland F - Search Results

1

Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.

Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, Trouplin V, Bianchi J, Aushev VN, Camonis J, Calabrese A, Borg-Capra C, Sippl W, Collura V, Boissy G, Rain JC, Guedat P, Delansorne R, Daviet L. Colland F, et al. Mol Cancer Ther. 2009 Aug;8(8):2286-95. doi: 10.1158/1535-7163.MCT-09-0097. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671755

2

Targeting ubiquitin specific proteases for drug discovery.

Daviet L, Colland F. Daviet L, et al. Among authors: colland f. Biochimie. 2008 Feb;90(2):270-83. doi: 10.1016/j.biochi.2007.09.013. Epub 2007 Sep 22. Biochimie. 2008. PMID: 17961905 Review.

3

Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.

Reverdy C, Conrath S, Lopez R, Planquette C, Atmanene C, Collura V, Harpon J, Battaglia V, Vivat V, Sippl W, Colland F. Reverdy C, et al. Among authors: colland f. Chem Biol. 2012 Apr 20;19(4):467-77. doi: 10.1016/j.chembiol.2012.02.007. Chem Biol. 2012. PMID: 22520753

4

Patented small molecule inhibitors in the ubiquitin proteasome system.

Guédat P, Colland F. Guédat P, et al. Among authors: colland f. BMC Biochem. 2007 Nov 22;8 Suppl 1(Suppl 1):S14. doi: 10.1186/1471-2091-8-S1-S14. BMC Biochem. 2007. PMID: 18047738 Free PMC article. Review.

5

Combination of active and inactive siRNA targeting the mitotic kinesin Eg5 impairs silencing efficiency in several cancer cell lines.

Formstecher E, Reverdy C, Cholay M, Planquette C, Trouplin V, Lehrmann H, Aresta S, Calabrese A, Arar K, Daviet L, Colland F. Formstecher E, et al. Among authors: colland f. Oligonucleotides. 2006 Winter;16(4):387-94. doi: 10.1089/oli.2006.16.387. Oligonucleotides. 2006. PMID: 17155913

6

Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase.

Cholay M, Reverdy C, Benarous R, Colland F, Daviet L. Cholay M, et al. Among authors: colland f. Exp Cell Res. 2010 Feb 15;316(4):667-75. doi: 10.1016/j.yexcr.2009.10.023. Epub 2009 Nov 10. Exp Cell Res. 2010. PMID: 19909739

7

Synthesis and biological evaluation of 9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes.

Colombo M, Vallese S, Peretto I, Jacq X, Rain JC, Colland F, Guedat P. Colombo M, et al. Among authors: colland f. ChemMedChem. 2010 Apr 6;5(4):552-8. doi: 10.1002/cmdc.200900409. ChemMedChem. 2010. PMID: 20186914

8

Integrating a functional proteomic approach into the target discovery process.

Colland F, Daviet L. Colland F, et al. Biochimie. 2004 Sep-Oct;86(9-10):625-32. doi: 10.1016/j.biochi.2004.09.014. Biochimie. 2004. PMID: 15556272 Review.

9

Ubiquitin-specific proteases as cancer drug targets.

Sippl W, Collura V, Colland F. Sippl W, et al. Among authors: colland f. Future Oncol. 2011 May;7(5):619-32. doi: 10.2217/fon.11.39. Future Oncol. 2011. PMID: 21568678 Review.

10

Identification of the Helicobacter pylori anti-sigma28 factor.

Colland F, Rain JC, Gounon P, Labigne A, Legrain P, De Reuse H. Colland F, et al. Mol Microbiol. 2001 Jul;41(2):477-87. doi: 10.1046/j.1365-2958.2001.02537.x. Mol Microbiol. 2001. PMID: 11489132 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters